
Chief Medical Officer at Krele Pharmaceuticals, Inc.
Greater New York City Area

Chief Medical Officer at Krele Pharmaceuticals, Inc.
Greater New York City Area
Current (2009-03-21) CV available at:
http://doctordeluca.com/Library/Personal/DelucaCV-current.pdf
Alex DeLuca was born in NYC in 1955. He attended Vassar and received his M.D. from the Albert Einstein College of Medicine. He completed Montefiore's Residency Program in Social Medicine, became board certified in Family Medicine and Addiction Medicine and an ASAM fellow, chaired ASAM's Review Course 1998-2000, and earned an Masters of Public Health degree from Columbia University in 2005.
From 1990, he was medical director at the Smithers Addiction Treatment Center, and was chief there 1998-2000. After, DeLuca did private practice in psychopharmacology, opioid pain management, and treatment of substance use disorders in a primary care setting.
In 2008 Dr. DeLuca joined Krele Pharmaceutical, Inc. as Chief Medical Officer. He is an independent consultant specializing in addiction and pain medicine and is an Expert Medical Witness and trial consultant defending physicians and patients caught up in a vicious drug war. Though he is on sabbatical as Senior Consultant and board member of the Pain Relief Network as of December 2008, he remains a pain relief advocate and a long-time advocate of harm reduction and is a friend of Moderation Management, Inc., having been more active in that organization 2000-2003.
DeLuca's Addiction, Pain and Public Health website, aka doctordeluca.com, is a rich resource of full text academic and journalistic resources and collections of related documents, and is especially focused on the areas of chronic pain, opioid therapy, the war on doctors, and substance use disorders - especially alcohol abuse and alcohol and opioid dependence including detoxification.
In April 2007 the War on Doctors/Pain Crisis blog was launched. In Jan. '08, DeLuca was instrumental in developing and launching PRN's Chronic Pain Forums: http://painreliefnetwork/forum/
..alex... (Revised: 2009-03--23)
Other areas of experience and expertise:
* medication development consultation services: study design, med and patent lit reviews, FDA approval and NIH grant processes, document and meeting preparation;
* treatment system design, especially the integration of addiction and pain therapy and the incorporation of clinical research teams into the fabric of medical treatment systems, towards better patient outcomes and development of research generated revenue streams.
(Pharmaceuticals industry)
December 2008 — Present (1 year )
Krele is developing high impact prescription drugs for unmet
medical needs. Krele has a portfolio of drug product candidates that target >$1 billion markets or emerging markets. Krele
tailors development to meet the challenges of each condition,
such as second-line treatment options for sub-specialty
physicians which can be expanded to larger markets after initial
FDA approval.
Krele has targeted intractable problems with fresh
ideas and experienced scientists and drug developers.
(Public Policy industry)
2004 — Present (5 years )
Pain Relief Network was founded in 2002 in response to the Bush Administration's crackdown on pain treating physicians. The Department of Justice launched its "Oxycontin Action Plan" in response to a DEA press campaign that asserted that Purdue Pharmaceuticals had unleashed an "epidemic" of drug abuse across the country, particularly in rural Appalachia. (The DEA’s OxyContin Action Plan: An Unproven Drug Epidemic)
PRN's Mission - To understand the legal and procedural mechanisms that result in certain conviction. To alert the media, and to help, as much as possible, the private attorneys who became involved in these overwhelming cases.
The Controlled Substances Act is fundamentally unlawful in that it deprives doctors and patients of their Constitutional rights. PRN would like to bring sanity, reason and compassion to this urgent debate, and they need your help to do it.
(Medical Practice industry)
2004 — Present (5 years )
Dr. DeLuca is an independent consultant specializing in addiction and pain medicine - please see current Brief Biography and CV for complete details; available at: [http://www.doctordeluca.com/Library/Personal/DelucaBio-current.htm]
(Pharmaceuticals industry)
2000 — 2001 (1 year )
(Non-Profit; 1001-5000 employees; Hospital & Health Care industry)
1999 — 2000 (1 year )
Senior Attending Physician, SLRCH, New York City, 10019
(Non-Profit; 1001-5000 employees; Hospital & Health Care industry)
1998 — 2000 (2 years )
Chief and Medical Director, Smithers Addiction Treatment and Research
Center (Smithers); and,
Head, Division of Combined Substance Abuse Services,
St. Luke’s / Roosevelt Hospital Center (SLRHC), New York City, 10019
(Pharmaceuticals industry)
1998 — 2000 (2 years )
(Non-Profit; 1001-5000 employees; Hospital & Health Care industry)
1994 — 1998 (4 years )
Associate Director for Medicine, Smithers, SLRHC, New York City, 10019
• Designed and implemented an Evaluation Unit to assess withdrawal, medical, and psychosocial problems of all patients using standardized,
validated assessment tools were employed to determine appropriate level of
care, based on the ASAM Patient Placement Criteria (PPC).
• Established, with Jeffrey Foote, Ph.D., a research center within the Evaluation Unit. This effort produced, as of 7/2000, some three million dollars in federal funding.
• Conceptualized, developed and programmed a computer database system, Trax!, which greatly facilitated our research and grant acquisition efforts, and ongoing program improvement.
• Greatly expanded outpatient detox from what had been an inpatient-only program.
(Pharmaceuticals industry)
1987 — 1988 (1 year )
1977 — 1981
BA , Biopsychology , 1973 — 1977